[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369343-105":59,"doc-detail-369343-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gabrd-accelerates-tumour-progression-via-regulating-ccnd1-signalling-pathway-in-gastric-cancer-original-article","GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer - ORIGINAL ARTICLE","","Neurotransmitters and their receptors influence tumour initiation and progression, yet their functions in gastric cancer remain insufficiently defined. This study identifies gamma-aminobutyric acid type A receptor subunit delta (GABRD) as a novel oncogene in gastric cancer and shows its preferential upregulation in tumour tissues relative to adjacent normal tissues. Elevated GABRD expression correlates with poor survival. GABRD knockdown triggers apoptosis and cell-cycle arrest, suppressing proliferation and migration in vitro and inhibiting tumour growth in vivo. Transcriptomic and Ingenuity pathway analyses indicate cyclin D1 (CCND1) as a downstream target, and immunohistochemistry links CCND1 with GABRD expression. Mechanistically, p53-dependent apoptosis is induced via CCND1, with GABRD promoting CCND1 by blocking ubiquitin-mediated degradation, providing new mechanistic insights for gastric tumourigenesis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gabrd-accelerates-tumour-progression-via-regulating-ccnd1-signalling-pathway-in-gastric-cancer-original-article/369343/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gabrd-accelerates-tumour-progression-via-regulating-ccnd1-signalling-pathway-in-gastric-cancer-original-article/369343.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does GABRD play in gastric cancer according to the study?","Question",{"text":112,"@type":113},"GABRD is identified as a novel oncogene and is preferentially upregulated in gastric cancer tissues. High GABRD expression is associated with poor prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does GABRD affect cancer cell behavior?",{"text":117,"@type":113},"GABRD knockdown induces apoptosis and cell-cycle arrest and represses proliferation and migration in vitro. It also suppresses tumour growth in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"How is CCND1 involved in the mechanism described?",{"text":121,"@type":113},"Cyclin D1 (CCND1) is highlighted as a potential downstream target of GABRD. Functional experiments indicate that GABRD regulation of proliferation, migration, invasion, and apoptosis depends on CCND1, with p53-dependent apoptosis mediated through this pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369343,1790260441,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of Cellular and Molecular Medicine  \nORIGINAL ARTICLE  OPEN ACCESS   \nGABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer  \nWeibing Leng1,2  | Jun Ye3 | Zhenpeng Wen2 | Han Wang4 | Zhenyu Zhu5 | Xilin Song5 | Kai Liu5  \n1Colorectal Cancer Center, Sichuan University West China Hospital, Chengdu, Sichuan, China | 2Department of Medical Oncology, Sichuan University West China Hospital, Chengdu, Sichuan, China | 3Department of Proctology, Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, Sichuan, China | 4West China School of Medicine, Sichuan University, Chengdu, Sichuan, China | 5Department of Gastrointestinal Surgery, Shandong Cancer  \nHospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China Correspondence: Kai Liu ([liukaizaichsh@126.com](liukaizaichsh@126.com))  \nReceived: 11 June 2024 | Revised: 10 February 2025 | Accepted: 27 February 2025  \nFunding: This work is supported by the Beijing Science and Technology Innovation Medical Development Foundation (KC2021-JX-0186-87); the Beijing Xisike Clinical Oncology Research Foundation (Y-HH202101-0340, Y-NESTLE2022MS-0426); and the Natural Science Foundation General Project of Shandong Province (ZR2021MH061) .  \nKeywords: cyclin D1 | gamma-aminobutyric acid type A receptor | gastric cancer | neurotransmitter receptors  \nABSTRACT  \nNeurotransmitters and their receptors were reported to be involved in tumour initiation and progression. However, little is known about their roles in gastric cancer (GC) . Here, we first identified gamma-aminobutyric acid type A receptor subunit delta (GABRD) as a novel oncogene in GC. GABRD was preferentially upregulated in GC tissues compared with adjacent normal tissues. High GABRD expression was significantly associated with poor survival prognosis. Knockdown of GABRD could markedly induce cell apoptosis and cell cycle arrest while repressing proliferation and migration in vitro, and suppress tumour growth in vivo. The results of transcriptomic analysis and Ingenuity pathway analysis (IPA) highlighted that cyclin D1(CCND1) was a potential downstream target. Immunohistochemistry results also indicated that CCND1 expression was associated with GABRD in GC. Functional experiments also confirmed that the role of GABRD in regulating proliferation, migration, invasion, and apoptosis was dependent on CCND1. Mechanically, further research confirmed that GABRD knockdown could induce p53-dependent apoptosis through CCND1, and GABRD upregulated CCDN1 through inhibiting its ubiquitin-mediated degradation. Overall, these findings uncover a role for the neurotransmitter receptor GABRD in regulating the proliferation and apoptosis of gastric cancer cells. Our present study provides novel insights into the mechanism of tumourigenesis in gastric cancer.  \n1 | Introduction  \nIn recent years, emerging data suggest the neurotransmitter/ receptor axis emerged as an essential microenvironmental component in influencing diverse malignant phenotypes of human cancers [1] . Neurotransmitter receptors have been detected in many tumour tissues and exert regulative effects in cancer cell  \nproliferation and dissemination [2–6] . Therefore, deciphering the functional mechanisms of the neurotransmitter/receptor axis in tumorigenesis is expected to pave the way for novel anticancer therapy [7] .  \nGamma-aminobutyric acid (GABA), known as the inhibitory neurotransmitter in the central nervous system, is also prevalent  \n\n| Abbreviations: CCND1, Cyclin D1; Co-IP, Co-Immunoprecipitation; GABRD, Gamma-aminobutyric acid type A receptor subunit delta; GC, gastric cancer; IHC, immunohistochemical; IPA, Ingenuity pathway analysis; TCGA, The Cancer Genome Atlas. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is proper","cbCaiqZvpmkjnnvT","https://ap.wps.com/l/cbCaiqZvpmkjnnvT","pdf",11796927,14,"English","# Introduction\n# Materials and Methods\n## TCGA Database Bioinformatics Analysis","[{\"question\":\"What role does GABRD play in gastric cancer according to the study?\",\"answer\":\"GABRD is identified as a novel oncogene and is preferentially upregulated in gastric cancer tissues. High GABRD expression is associated with poor prognosis.\"},{\"question\":\"How does GABRD affect cancer cell behavior?\",\"answer\":\"GABRD knockdown induces apoptosis and cell-cycle arrest and represses proliferation and migration in vitro. It also suppresses tumour growth in vivo.\"},{\"question\":\"How is CCND1 involved in the mechanism described?\",\"answer\":\"Cyclin D1 (CCND1) is highlighted as a potential downstream target of GABRD. Functional experiments indicate that GABRD regulation of proliferation, migration, invasion, and apoptosis depends on CCND1, with p53-dependent apoptosis mediated through this pathway.\"}]","GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer - ORIGINAL ARTICLE | PDF",1790182148,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/730cce5a9feef622cd3701423b1281bf.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bb5127d8abfe2affdcdd0ef6aaadae0.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/841fc657dc9f661e950d9390c9e08d15.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/349a0c9fe58def635d31e0f216c228ba.webp",980,1287]